Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Clinical Study of Human Umbilical Cord-Derived Mesenchymal Stromal Cells in the Treatment of Primary Biliary Cholangitis With Inadequate Response to Ursodeoxycholic Acid

NCT07795151 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.

NCT NCT07795151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07795151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Clinical Study of Human Umbilical Cord-Derived Mesenchymal Stromal Cells in the Treatment of Primary Biliary Cholangitis With Inadequate Response to Ursodeoxycholic Acid
Lead sponsor
Beijing 302 Hospital
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
August 31, 2030
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary biliary cholangitis